Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
Nicolas Boissel(Hôpital Saint-Louis), Claude Preudhomme(Centre National de la Recherche Scientifique), André Baruchel(Hôpital Saint-Louis), Stéphane de Botton(Université Paris-Sud), Harmony Leroy(Hôpital Albert Calmette), Anne Auvrignon(Sorbonne Université), Hervé Dombret(University of London Institute in Paris), Thierry Leblanc(Hôpital Saint-Louis), N Philippe(Inserm), Emmanuel Raffoux(Université Paris Cité), Olivier Hermine(Délégation Paris 5), Bruno Quesnel(Inserm), Xavier Thomas(Hôpital Lyon Sud), Guy Leverger(Sorbonne Université), Benoît Brethon(Hôpital Saint-Louis)
Cited by 355
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k